Researchers who found that underdeveloped liver enzyme pathways in some infants may make it harder for them to process toxic ingredients in vaccines — a condition that could lead to SIDS — said their study, published in the International Journal of Medical Sciences, could lead to therapeutic interventions that could save lives.